Kate Dellorusso
Stock Analyst at LifeSci Capital
(0.42)
# 4,433
Out of 5,078 analysts
21
Total ratings
38.9%
Success rate
-14.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kate Dellorusso
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACRS Aclaris Therapeutics | Reiterated: Buy | $13 | $3.75 | +246.67% | 3 | Oct 1, 2026 | |
| UPB Upstream Bio | Reiterated: Buy | $19 | $2.74 | +593.43% | 14 | Sep 1, 2026 | |
| MREO Mereo BioPharma Group | Reiterated: Hold | n/a | $0.2817 | - | 4 | Aug 15, 2026 |
Aclaris Therapeutics
Oct 1, 2026
Reiterated: Buy
Price Target: $13
Current: $3.75
Upside: +246.67%
Upstream Bio
Sep 1, 2026
Reiterated: Buy
Price Target: $19
Current: $2.74
Upside: +593.43%
Mereo BioPharma Group
Aug 15, 2026
Reiterated: Hold
Price Target: n/a
Current: $0.2817
Upside: -